Agentix (AGTX) Other Working Capital Changes (2013 - 2026)
Agentix's (AGTX) quarterly Other Working Capital Changes came in at -$95797.0 in Q2 2025, down 265.06% YoY from $58036.0 in Q2 2024, and down 91.44% on a QoQ basis from -$50041.0 in Q1 2025.
Agentix (AGTX) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Agentix (AGTX) has 5 years of Other Working Capital Changes data on file, last reported at -$95797.0 in Q2 2025.
- Quarterly Other Working Capital Changes fell 265.06% year-over-year to -$95797.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$157874.0 (down 10.33% YoY) and the FY2026 annual result came in at -$95798.0, down 2270.65% from the prior year.
- Other Working Capital Changes fell to -$95797.0 in Q2 2025, from -$50041.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $109963.0 in Q4 2022 to a low of -$331106.0 in Q1 2023.
- A 4-year average of -$39871.8 and a median of -$10583.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 154.25% — and 2025, when it plunged 6662.3%.
- Tracing AGTX's Other Working Capital Changes over 4 years: stood at $109963.0 in 2022, then plunged by 272.6% to -$189801.0 in 2023, then surged by 90.63% to -$17777.0 in 2024, then tumbled by 438.88% to -$95797.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$95797.0 (Q2 2025), -$50041.0 (Q1 2025), and -$17777.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 |
| Jun 30, 2026 | -1.00 |
| Jun 30, 2026 | -1.00 |
| Jun 30, 2025 | -95,797.00 |
| Jun 30, 2025 | -95,797.00 |
| Jun 30, 2025 | -95,797.00 |
| Mar 31, 2025 | -50,041.00 |
| Mar 31, 2025 | -50,041.00 |
| Mar 31, 2025 | -50,041.00 |
| Dec 31, 2024 | -17,777.00 |
| Dec 31, 2024 | -17,777.00 |
| Dec 31, 2024 | -17,777.00 |
| Sep 30, 2024 | 5,741.00 |
| Sep 30, 2024 | 5,741.00 |
| Sep 30, 2024 | 5,741.00 |
| Jun 30, 2024 | 58,036.00 |
| Jun 30, 2024 | 58,036.00 |
| Jun 30, 2024 | 58,036.00 |
| Mar 31, 2024 | -740.00 |
| Mar 31, 2024 | -740.00 |